Cells protected by AAGP® were subjected to UVA, UVC, hydrogen peroxide, inflammatory (ILβ), time, temperature (-196°C, -80°C, -3°C, 3°C, 4°C, 15°C and 22°C) and low serum induced cell death at a pH of 5.3-10.5, in a laboratory setting. The average increase in cell survival credited to AAGP® in the face of these conditions was over 55%. This cannot be attributed to AAGP® increasing cell proliferation as it has been found that AAGP® has no effect on cell doubling times in either Hela or fibroblast cells.

In addition to protecting cell survival, AAGP® has also been shown to preserve cell functionality. This has been tested not only with stem cell markers and CD34+ functionality tests but also in vivo studies where AAGP®-treated transplanted islet cells were found to reduce blood glucose concentrations in diabetic mice by 40% by day 40 in comparison to islet cells which were transplanted into mice without first being exposed to AAGP®.